SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050933
Filing Date
2018-08-09
Accepted
2018-08-09 16:03:22
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14068_110q.htm 10-Q 1183627
2 EX-10.1 a18-14068_1ex10d1.htm EX-10.1 419653
3 EX-10.2 a18-14068_1ex10d2.htm EX-10.2 87360
4 EX-31.1 a18-14068_1ex31d1.htm EX-31.1 13334
5 EX-31.2 a18-14068_1ex31d2.htm EX-31.2 12799
6 EX-32.1 a18-14068_1ex32d1.htm EX-32.1 7178
7 EX-32.2 a18-14068_1ex32d2.htm EX-32.2 7173
  Complete submission text file 0001104659-18-050933.txt   5651051

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT loxo-20180630.xml EX-101.INS 1268570
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20180630.xsd EX-101.SCH 40234
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20180630_cal.xml EX-101.CAL 34672
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20180630_def.xml EX-101.DEF 131023
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20180630_lab.xml EX-101.LAB 349961
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20180630_pre.xml EX-101.PRE 237706
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 181004967
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences